Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of TQ-B3101?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel or logistical considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

Question 6

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) clinical trial (NCT03972189). Contact the study team or your healthcare provider for specific answers.

What this study is about